Researchers say poliovirus may help treat brain cancer - ABC News
glioblastoma | Duke Cancer Institute
Tetanus Vaccine Helps Improve Survival in People with Glioblastoma | Duke Health
Modified polio vaccine helps fight deadly brain tumors
Brain immunology and immunotherapy in brain tumours | Nature Reviews Cancer
St. Lucie families cautious about cancer treatment 'breakthrough'
Poliovirus Therapy for Glioblastoma has Three-Year Survival Rate of 21 Percent | Duke Today
glioblastoma | Duke Cancer Institute
Brain Tumor Immunotherapy: 9780896036383: Medicine & Health Science Books @ Amazon.com
Immunotherapy for Glioblastoma Well Tolerated; Survival Gains Observed | Duke Cancer Institute
Duke SPORE in Brain Cancer | TRP
Duke's Brain Tumor Center Marks 85 Years | Duke Department of Neurosurgery
Poliovirus Therapy Shows Potential as Cancer Vaccine in Lab Studies | Duke Health
Positive trial results for Valneva Covid vaccine - BBC News
Brain Cancer Research: Duke University therapy attacks brain tumors | Raleigh News & Observer
Frontiers | Making a Cold Tumor Hot: The Role of Vaccines in the Treatment of Glioblastoma
Researchers Discover Tetanus Shot Can Successfully Aid in Brain Cancer Treatment
Immunomic Therapeutics Assumes Sponsorship of ATTAC II IND for a Brain Cancer Vaccine — Duke OTC
Brain Cancer Vaccine-Chemotherapy Combo Shows Promise
The Preston Robert Tisch Brain Tumor Center at Duke | Duke Department of Neurosurgery
Brain Tumor Research Featured in People Magazine | Duke Health
Duke Team Finds Missing Immune Cells That Could Fight Lethal Brain Tumors - Drug Discovery and Development
A Promising Brain Tumor Vaccine Is On Its Way - Scientific Animations
Poliovirus Therapy Induces Immune Responses Against Cancer | Duke Cancer Institute
Polio to treat cancer? Scott Pelley reports on Duke clinical trial - CBS News
Duke Researchers Find Simpler, More Effective Cancer Vaccine Approach | Duke Health
Modified polio vaccine helps fight deadly brain tumors
Poliovirus Therapy Shows Early Promise for Treating Aggressive Brain Cancer, but Questions Linger - Scientific American
